Stay updated with breaking news from Ers Genomics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.
/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with the CHUM Research Centre ('(CRCHUM),'). This is a...
ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of the 2020 Nobel Prize in Chemistry for her pioneering work on CRISPR/Cas9, provides access to the definitive patent portfolio for this groundbreaking technology.
/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Demeetra AgBio ('Demeetra'). This is a non-exclusive licensing...
/PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Demeetra AgBio ('Demeetra'). This is a non-exclusive licensing...